Lumida
/NUS
⌘K
NU Skin Enterprises Inc

NU Skin Enterprises Inc

NUS
$4.85USD-0.61%-0.03 today

MARKET CAP

236.1M

P/E (TTM)

4.5x

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$4
$15

AI Summary

Stalk
Sell NowMedium

The asset is firmly in a Stage 4 decline with dominant lower highs and lower lows, down-trending moving averages, and persistent distribution. Medium-term bias is bearish, supported by structural downtrend and bearish pattern implications. Short-term price has attempted a bounce but was rejected at falling EMAs, indicating execution readiness for selling. The long-term secular trend remains negative. Risks include possible oversold mean-reversion bounces and a reclaim of EMAs that could signal a reversal.

  • Dividend yield of 4.9% exceeds industry average, boosting income.
  • High earnings yield suggests attractive valuation versus peers.
  • Negative profitability metrics point to low margin conversion.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.7B$2.2B$2.0B$1.7B$1.5B
YoY %+4.4%-17.4%-11.5%-12.0%-14.3%
P / Sales1.0x1.0x0.5x0.2x0.3x
EV / Sales1.2x1.3x0.9x0.6x0.6x
Gross Profit, Adj.$2.0B$1.6B$1.4B$1.2B$1.0B
YoY %+5.0%-21.1%-14.9%-12.9%-12.7%
Margin %75.0%71.7%68.9%68.2%69.4%
EV / Gross Profit1.6x1.8x1.3x0.8x0.8x
EBITDA, Adj.$410.9M$231.8M$139.0M$120.6M$143.1M
YoY %+8.8%-43.6%-40.1%-13.2%+18.7%
Margin %15.2%10.4%7.1%7.0%9.6%
EV / EBITDA7.9x12.0x12.5x8.1x5.9x
EBIT$234.0M$110.8M$48.3M$-151.6M$65.8M
YoY %-9.2%-52.6%-56.5%-414.0%+143.4%
Margin %8.7%5.0%2.5%-8.8%4.4%
EV / EBIT13.9x25.2x36.1x-6.4x12.9x
Net Income$147.3M$104.8M$8.6M$-146.6M$160.2M
YoY %-23.0%-28.9%-91.8%-1805.6%+209.3%
Net Margin5.5%4.7%0.4%-8.5%10.8%
EPS (GAAP)$2.86$2.07$0.17-$2.95$3.18
YoY %-21.2%-27.6%-91.8%-1835.3%+207.8%